These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Controversies in primary prevention among hyperlipidemic patients.
    Author: McPherson R.
    Journal: Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678.
    Abstract:
    Data from a number of population-based primary prevention trials clearly indicate that reducing total serum cholesterol levels leads to a reduced risk of coronary artery disease and death. Similarly, for patients with coronary artery disease, reducing total serum cholesterol levels proved to be an effective secondary prevention strategy, leading to a reduced risk of coronary events and death. Targeting high risk patients is a particularly important component of primary prevention. The overall benefit of treatment is significantly reduced when cholesterol-lowering strategies are initiated later in life. To assist in both primary and secondary prevention strategies, an outline of guidelines developed by a Health Canada working group for the management of hyperlipidemia have recently been published.
    [Abstract] [Full Text] [Related] [New Search]